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Introduction: In an age of increasing scrutiny of each hospital admission, emergency department 
(ED) observation has been identified as a low-cost alternative. Prior studies have shown admission 
rates for syncope in the United States to be as high as 70%. However, the safety and utility 
of substituting ED observation unit (EDOU) syncope management has not been well studied. 
The objective of this study was to evaluate the safety of EDOU for the management of patients 
presenting to the ED with syncope and its efficacy in reducing hospital admissions.
Methods: This was a prospective before-and-after cohort study of consecutive patients presenting 
with syncope who were seen in an urban ED and were either admitted to the hospital, discharged, 
or placed in the EDOU. We first performed an observation study of syncope management and then 
implemented an ED observation-based management pathway. We identified critical interventions 
and 30-day outcomes. We compared proportions of admissions and adverse events rates with a chi- 
squared or Fisher’s exact test.
Results: In the “before” phase, 570 patients were enrolled, with 334 (59%) admitted and 27 (5%) 
placed in the EDOU; 3% of patients discharged from the ED had critical interventions within 30 days 
and 10% returned. After the management pathway was introduced, 489 patients were enrolled; 34% 
(p<0.001) of pathway patients were admitted while 20% were placed in the EDOU; 3% (p=0.99) of 
discharged patients had critical interventions at 30 days and 3% returned (p=0.001). 
Conclusion: A focused syncope management pathway effectively reduces hospital admissions and 
adverse events following discharge and returns to the ED. [West J Emerg Med. 2019;20(2)250–255.]
INTRODUCTION
Prior studies have shown admission rates for syncope 
in the United States (U.S.) to be as high as 70%, triggering 
at least 2% of hospital admissions from the emergency 
department (ED) and 460,000 hospitalizations annually.1-3 
Although emergency medicine has become more adept at 
Harvard Medical School, Beth Israel Deaconess Medical Center, Department of 
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Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, 
Pennsylvania
*
†
distinguishing high-risk syncope from syncope of benign 
etiology and safety in ED discharge, there is a paucity of data 
addressing the care of patients once the ED recognizes a need 
for admission or further management.4-17  Recent data note that 
a typical hospital admission in the U.S. for syncope averages 
$5,300 with a total cost of syncope-related admissions of over 
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What do we already know about this issue?
Although emergency department (ED) 
observation has been utilized for syncope, 
the safety and maximal utility of substituting 
ED observation for in-house care in syncope 
has not been well studied.
What was the research question?
This study aimed to evaluate the safety 
and effectiveness of an ED management 
Observation Pathway.
What was the major finding of the study?
A syncope management observation 
pathway reduced hospital admissions and 
adverse events, when compared to standard 
ED or inpatient care.
How does this improve population health?
With rising health care costs, hospital 
crowding, and increased ED boarding, a 
syncope management pathway is reliable, 
safe, and effective for ED patients. 
$2 billion per year.1-3, 16-21 These costs have been directly related to 
the broad diagnostic testing performed to discover the etiologies 
of syncope.20 Not unexpectedly then, syncope was recently noted 
to be the leading diagnosis associated with payment denials by 
the Centers for Medicare and Medicaid Services.22 
As short hospital-inpatient stays and hospital readmissions 
undergo increased scrutiny, ED observation units (EDOU) are 
increasingly being used as a low-cost alternative to inpatient 
hospitalization. While efforts to reduce unnecessary and 
expensive admission have generated clinical decision guidelines 
regarding the decision to admit, they have only begun to assess 
the value and yield of testing in syncope and have not fully 
assessed the utility of expedited care in an observation unit.23-24 
The safety of substituting ED observation for in-house care in 
syncope has not been well studied. The objective of this study 
was to evaluate the utility and safety of an ED observation-based 
management pathway for the evaluation of patients presenting to 
the ED following a syncopal event. 
METHODS
Study Design and Setting
This was a prospective cohort before-and-after study 
conducted in a large, urban teaching hospital with an annual 
ED census of 56,000 and an annual ED observation volume of 
approximately 6,000 visits. We performed an observational study 
of consecutive patients with syncope who were initially seen in 
the ED and were either admitted to the hospital, discharged or 
placed in an EDOU. We then implemented an ED-based, focused 
management pathway – the Boston Syncope Management 
Pathway (BSCMP) – to investigate the outcomes of these patients 
who presented to the ED with syncope (Figure). The BSCMP 
was derived by emergency physicians (EP) and cardiologists to 
create individualized workups for syncope based on presenting 
symptoms and comorbidities. The derivation used preexisting 
medical literature evaluating care of patients with syncope.2, 9, 
11-16  Institutional review board approval was obtained prior to 
initiation of the study.
Selection of Participants
Inclusion criteria were as follows: 1) age 18 years or older; 
and 2) ED patients presenting with syncope or near syncope 
and admitted by the ED team to either an inpatient ward or 
EDOU. We defined syncope as a sudden and transient (< five 
minutes) loss of consciousness producing a brief period of 
unresponsiveness and a loss of postural tone ultimately resulting 
in spontaneous recovery requiring no resuscitation measures.9, 
17 Near syncope was defined as “feeling like they were going to 
pass out” but without actual loss of consciousness. Exclusion 
criteria were patients discharged home directly from the ED 
without an observation stay, patients with persistent altered 
mental status, alcohol or illicit drug-related loss of consciousness, 
seizure, coma, hypoglycemia, or transient loss of consciousness 
caused by head trauma.
Outcome Measures
The primary outcome was the utility of the BSCMP for 
the management of patients presenting to the ED with syncope. 
Secondary outcomes looked at the efficacy of the pathway in 
reducing hospital admissions and improving patient disposition. 
We defined significant events, as has been defined previously, to 
include critical interventions such as pacemaker or defibrillator 
placement, percutaneous coronary intervention, surgery, blood 
transfusion, cardiopulmonary resuscitation, endoscopy and 
carotid artery interventions, or adverse outcomes such as death, 
pulmonary embolus, myocardial infarction, cerebrovascular 
accident, dysrhythmia, cardiac arrest, intracranial hemorrhage 
or sepsis.6 We made secondary comparisons for patient 
demographics, comorbidities, and other features of their clinical 
presentation based on inpatient vs EDOU admission. 
Data Collection and Processing
An electronic ED dashboard that interfaced with a 
commercially available healthcare information system 
automatically tracked all ED patients, identifying and flagging 
those with complaints of syncope, near syncope or loss 
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of consciousness for provider enrollment. In addition, the 
investigators routinely reviewed daily patient logs to ensure 
appropriate pathway enrollment and identify missed patients. The 
ED dashboard does not allow for a physician to place a patient 
disposition without enrolling (with a written explanation) or 
declining pathway placement. A chart review was then performed 
of these patients reviewing their ED and EDOU or hospital 
course. Finally, we recorded outcomes at 30 days following initial 
presentation to the ED mainly via medical record reviews and a 
few through phone calls.
Primary Data Analysis
We entered data into a RedCap database. Categorical data 
was then analyzed using either chi-squared or Fisher’s exact test. 
We analyzed continuous data using Student’s t-test. Results are 
reported as percentages. 
RESULTS
Patient demographics and comorbidities pre- and post-
pathway are described in Table 1. These show a slightly older 
population in the post-pathway group with significantly fewer 
signs of acute coronary syndrome or signs of conduction disease; 
however, they indicated more worrisome cardiac history, valvular 
heart disease, and abnormal vital signs. As described in Table 
2, prior to implementation of the BSCMP, of the 570 patients 
enrolled, 344 (58.6%) were fully admitted and 27 (4.7%) were 
placed in the EDOU. A total of 209 (36.7%) patients were 
discharged immediately following ED evaluation. After the 
pathway was introduced, 489 patients were enrolled. Of the 489 
patients enrolled, 164 (33.5%) were admitted and 96 (19.6%) 
were placed in the EDOU. More patients were discharged directly 
from the ED to home in the post-pathway vs pre-pathway studies 
(36.7% vs 46.8%; p<0.001). The observation unit post-BSCMP 
All patients should have orthostatic blood pressure measured*
All positive or equivocal tests should generate a cardiology consult or admission
I. Signs and symptoms of acute coronary syndrome
a. Includes: Chest pain or shortness of breath of possible cardiac origin electrocardiogram or new (or not known to be old STT 
wave change, Ischemic ECG changes (ST elevation or deep [>0.1 mV] ST depression)
b. Workup: Serian trigeminal neuralgia and stress testing (consider stress echo). If obvious ischemia then admit.
II. Worrisome cardiac history
a. Includes: History of coronary artery disease, including deep q waves, hypotrophic or dialated cardiomyopathy. History 
of congestive heart failure or left ventrical dysfuntion, history of ventricular tachycardia/ventricular fibrillation, permanent 
pacemaker, implantable cardioverter-defibrillator, pre-hospital use of anti-dysrhythmic medication
b. Workup: Echo (in none in the last six months) and telemetry
III. Family history of sudden death
a. Includes: Family history (first degree relative) with sudden death, hypertrophic cardiomyopathy, Brugada’s syndrome or 
long QT syndrome
b. Workup: Echo, telemetry and ambulatory home monitoring
IV. Valvular heart disease
a. Includes: Heart murmur noted in history or on emergency department (ED) examination not fully evaluated in the past six months
b. Workup: Telemetry, echo, ambulatory monitoring
V. Signs of conduction disease
a. Includes: Tachy or bradysrhythmias in ED, QT interval >500, Brugada, Wolff-Parkinson-White, multiple syncopal episodes 
within the last six months, palpations, syncope during exercise
b. Workup:Telemetry, ambulatory monitoring, consider echo and stress testing
VI. Volume depletion
a. Includes: Gastrointestinal bleeding by hemoccult or history, hematocrit <30, dehydration not corrected in the ED per treating 
physician discretion
b. Workup: Follow gastrointestinal bleed pathway or hydrate and repeat complete blood count, electrolytes in the morning
VII. Persistent (>15 minutes) abnormal vital signs in the ED without need of concurrent interventions such as oxygen, pressors, 
temporary pacemakers
a. Includes: Respiratory rate >24 beats/minute, blood pressure <90 mmHg, O2 saturation <90%, sinus rate <50 beats/minute 
or sinus rate >100 beats/minute
b. Workup: Telemetry and echo
VIII. CNS (excluding clear subarachnoid hemorrhage, transient ischemic attack, stroke) or similar concerns
a. Includes: Headache, neuro symptoms, neuro deficit or anticoagulated
b. Workup: Head computed tomography if positive-neuro or neurosurgery consult
*Orthostatic blood pressure
• Blood pressure and heart rate after patient quietly supine for five minutes and after one minute and three minutes of standing
Figure. Boston Syncope Pathway to guide the management of patients with syncope in the emergency department. This is a validated 
pathway for the management of syncope in the ED.6
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Pre-pathway Post-pathway P value
Discharged 209 229 -
Return ED Visit 10% (21) 2.6% (6) 0.001
30-Day AE 3% (6) 3% (7) p<0.99
Table 3. Return visits to the emergency department (ED) and 30-
day adverse events (AE).
Pre-pathway Post-pathway P value
Number of patients 570 489 -
Age, mean (SD) 53.6 (24.2) 56.7 (22.8) 0.03
Male, % (n)
Risk factors
Signs of ACS (chest pain, ischemic, SOB, abnormal heart rhythm) 26.1% (149) 13.5% (66) <0.001
Signs of conduction disease (recurrent syncope, palpitations, syncope with 
exercise, QT > 500 ms, heart block)
13.5% (77)  8.4% (41) <0.01
Worrisome cardiac history (CAD, CHF, V-tach, pacemaker, ICD) 33% (188) 41% (201) <0.01
Valvular heart disease (i.e. significant murmur) 4% (23) 7% (35) 0.03
Family history of sudden death 2% (11) 0.8% (4) 0.19
Persistent abnormal vital signs in ED (RR>24, O2<90, HR<50 or >100, SBP<90) 6.5% (37) 17% (83) <0.001
Volume depletion (GIB, Hct < 30, profound dehydration) 6% (34) 8% (38) 0.24
Primary CNS event 1% (7) 2% (12) 0.17
Table 1. Patient demographics and risk factors for adverse outcomes in syncope; pre and post-pathway.
SD, standard deviation; ACS, acute coronary syndrome; SOB, shortness of breath; CAD, coronary artery disease; CHF, congestive 
heart failure; V-tach, ventricular tachycardia; ICD, implantable cardioverter-defibrillator; ED, emergency department; SBP, systolic blood 
pressure; HR, heart rate; GIB, gastrointestinal bleed; Hct, hematocrit; CNS, central nervous system.
Pre-pathway Post-pathway P value
Number of patients 570 489 -
Admitted 58.6%(334) 33.5% (164) p<0.001
ED Obs 4.7% (27) 19.6% (96) p<0.001
Discharged 36.7% (209) 46.8 (229) p<0.001
Table 2. Comparison of pre-pathway and post-pathway 
admission, emergency department observational (ED Obs), and 
discharged patients.
managed 96 (19.6%) patients presenting to the ED for syncope 
vs 27 (4.7%) prior to pathway implementation (p<0.001). Of the 
patients placed in the EDOU, 11 (11.4%) were admitted from the 
EDOU. 
As described in Table 3, of the 209 discharged patients 
from the ED, prior to the management pathway 21 (10%) 
returned to the ED for syncope. In comparison to the post-
pathway cohort, only six (2.6%)  re-presented to the ED for 
syncope after discharge (p=0.001). Although return visits 
decreased among discharged patients post pathway, 30-day 
adverse events were similar for these groups. Pre-pathway, 
30-day adverse events were 3% (6/209) vs 3% (7/229; p=0.99) 
post-pathway. Table 4 describes the pre- and post-pathway 30-
day return diagnoses post-discharge for syncope.
DISCUSSION
Our data suggest that a focused syncope management 
pathway may effectively reduce hospital admissions without 
increasing adverse events following discharge. EDOUs were 
designed to provide focused care in lieu of admission, with 
an expectation of discharge within 24 hours. The utility 
of ED observation has long been established for patients 
with diagnoses such as chest pain, asthma, congestive heart 
failure, and cellulitis, which in the past would often result 
in short hospital stays.25-29 Like chest pain, syncope is a 
common presentation that uncommonly signifies a dangerous, 
underlying condition and should be amenable to this approach.
The BSCMP was designed to direct care and refocus EPs 
not only in differentiating life threats from less-dangerous 
causes of syncope but to enable the EP to selectively manage 
those patients with potential risk factors for adverse event. 
To do so, the pathway directs physicians toward testing in 
fixed circumstances and to discharge patients who are low 
risk based on the BSCMP.6 Lastly, if neither the EDOU nor 
discharge is appropriate, the pathway recommends admission. 
This, in turn, likely reflects the broad spectrum of diseases that 
syncopal etiologies span, from potentially life-threatening to 
low-risk diagnoses.
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Pre-pathway (n=6/209) 
discharged
Post-pathway (n = 7/229) 
discharged
Myocardial infarction= 1 Anemia requiring transfusion= 1
PCI/surgery= 1 Vaginal bleed= 1
Ventricular dysrhythmia= 1 Ventricular tachycardia= 1
GI bleed=1 Death= 1
PE= 1 Surgery= 3
Sepsis= 1
Table 4. Description of return adverse events after discharge.
PCI, percutaneous coronary intervention; GI, gastrointestinal; PE, 
pulmonary embolism.
A prior study comparing an ED observation syncope 
protocol and routine inpatient admission found that 
observation reduced admission rates and hospital length of 
stay with no differences in 30-day quality-of-life scores or 
patient satisfaction.30,31 This study also suggested a reduction 
in hospital costs, with no difference in safety.30 We believe the 
BSCMP takes this one step further, as our data suggest not 
only a reduction in admission rates but a significant decrease 
in the number of returns and readmissions to the hospital for 
syncope patients. Given the financial constraints involved 
in the current healthcare climate, this finding becomes 
increasingly significant.
While fewer than one-third of EDs currently have 
EDOUs, this number is growing and our ability to 
adequately care for these growing patient populations needs 
to be commensurate.
LIMITATIONS
There are a number of limitations in this study, 
including possible selection bias in assigning patients to 
observation units vs inpatient admission. Additionally, the 
demographics were different: The pre-pathway population 
was younger and had clearly different risk factors than the 
post-pathway group. We also used a single institution for a 
test site, where the use of the BSCMP is well engrained as a 
practice guideline. This results in a lack of generalizability 
of the conclusions of this study. The sample size of this 
study was small, and there was lack of long-term follow-up 
>30 days in these patients. For each adverse outcome that 
was reported, discerning an outcome as causative may not 
always be uniform.
CONCLUSION
A focused syncope management pathway may effectively 
reduce hospital admissions and, in turn, minimize adverse 
events following discharge and potentially decrease the total 
number of returns to the ED in the ensuing 30 days.
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